ACCESS BIO, INC.

SOMERSET, NEW JERSEY 08873

Minority Owned
$340.65M
Total Contract Value
12 awards
First Award
Nov 22, 2022
Last Award
Nov 7, 2024
Business Size
small
CAGE Code
3CNE1

Top Industries (NAICS)

NAICS CodeObligationsAwards
325413$340.65M12

Contract Awards

3 awards found

75A50223C00035
Department of Health and Human Services
$88.70M
Sep 20, 2023

OVER THE COUNTER (OTC) COVID-19 TESTS

NAICS: 325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURINGFY2023
75A50223C00013
Department of Health and Human Services
$46.75M
Mar 13, 2023

THE PURPOSE OF THIS CONTRACT IS TO PROCURE OVER THE COUNTER (OTC) COVID-19 TESTS.

NAICS: 325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURINGFY2023
SPE2DS23F0035
Department of Defense
$205.20M
Dec 22, 2022

8509606737!CARESTART COVID-19 ANTIGEN H

NAICS: 325413 - IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURINGFY2023

Business Details

UEI
EZEJBJ28AMV4
CAGE Code
3CNE1
Address
SUITE A
65, CLYDE ROAD
SOMERSET, NJ 08873
Congressional District
NJ-12

Parent Company

ACCESS BIO, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov